INTRODUCTION
stability regulates BUBR1 phosphorylation, a BUBR1 mutant that entirely lacks the 186 pseudokinase domain (BUBR1-731X) but renders the protein hyperstable relative to the 187 WT 49 , also did not display a gel mobility shift (Fig 2C) . 188 To explore the effect of the pseudokinase on BUBR1 phosphorylation in more 189 detail, we monitored KARD phosphorylation at S676 and S670 with phospho-specific 190 antibodies 52,53 . In agreement with previous reports, both residues were highly 191 phosphorylated in prometaphase-arrested cells depleted of endogenous BUBR1 but 192 expressing BUBR1-WT. However, in cells expressing the hyperstable BUBR1-731X or 193 the unstable BUBR1-DKD, phosphorylation at both KARD sites was reduced (Fig 2D, E; 194 Suppl. Fig 2B-C) . Phosphospecific signals were normalized by total BUBR1 levels, 195 indicating that this is not an effect of variability in BUBR1 kinetochore levels. The same 196 results were obtained by Western blotting (Fig 2F) . To determine whether BUBR1 197 pseudokinase mutants are at all amenable to phosphorylation, we treated cells 198 expressing BUBR1-WT and -731X with okadaic acid to inhibit endogenous phosphatases 199 which resulted in a mobility upshift in both instances but no restoration of S676 200 phosphorylation in BUBR1-731X suggesting that the pseudokinase is absolutely required 201 for proper phosphorylation of the KARD (Fig 2G) . Taken together, our data confirm that 202 hBUBR1 is indeed a catalytically inactive during mitosis, and that the presence of a stable 203 pseudokinase domain per se and not its catalytic activity is a requisite for hBUBR1 mitotic 204 phosphorylation in the KARD. 205 The BUBR1 pseudokinase domain is required for PP2A-B56 kinetochore 206 recruitment and downstream phosphatase signalling 207 10 PP2A-B56 binding to the outer kinetochore is mediated through the KARD of 208 BUBR1 and is strongly promoted by phosphorylation at the aforementioned PLK1 and 209 CDK1 sites 22, 24 . Therefore, the decrease in KARD phosphorylation caused by 210 pseudokinase domain truncation or instability prompted us to assess if PP2A-B56 binding 211 to BUBR1 is attenuated in pseudokinase mutants. To ensure homogenous expression of 212 BUBR1 mutants, we generated inducible stable cell lines expressing 3xMYC-GFP-tagged 213 BUBR1-WT, -SKD, -DKD, and -731X and titrated doxycycline to obtain equivalent 214 kinetochore levels of the different BUBR1 constructs (Suppl. Fig 3A) . We analyzed HA-215 B56α kinetochore recruitment in nocodazole-arrested cells depleted of all B56 isoforms 216 by siRNA 32 . As expected, B56α localized at kinetochores of prometaphase arrested cells, 217 but it was greatly reduced in BUBR1 depleted cells (Suppl. Fig 3B) . Expression of 218 BUBR1-WT in cells depleted of endogenous BUBR1 restored kinetochore localization of 219 B56α, whereas expression of BUBR1-731X, -DKD or -SKD at similar levels did not ( Fig.   220   3A) . Therefore, the BUBR1 pseudokinase domain regulates PP2A-B56 docking to the 221 outer kinetochore, likely through KARD phosphorylation.
222
The BUBR1-bound pool of PP2A-B56 is responsible for dephosphorylating KNL1, 223 which induces SAC silencing by two major mechanisms: first, by dephosphorylating PP1 224 phosphatase recruitment motifs on KNL1 (including S24 in the SILK motif, 58,59 ) promoting 225 its binding and further dephosphorylation of the kinetochore and secondly, by targeting 226 KNL1 MELT motifs and inducing BUB1, BUB3 and BUBR1 delocalization 31, 35, 37 . We 227 reasoned that cells expressing BUBR1 pseudokinase mutants would exhibit 228 comparatively weaker changes in these phosphosites after B56 depletion as a result of 229 loss of PP2A-B56 signalling. In both control and BUBR1-WT expressing cells, we 230 observed a significant increase in BUB1 localization to kinetochores, and in KNL1 S24 231 phosphorylation, as expected (Fig 3B-C) . However, expression of BUBR1-731X, -DKD, 232 or -SKD resulted in smaller changes that were not statistically significant. These 233 observations suggest that the pseudokinase domain can indeed modulate downstream 234 signalling from PP2A-B56. 236 Considering the role of KARD phosphorylation in B56 interaction, we next 237 reasoned that SAC silencing may be weakened in cells expressing BUBR1 pseudokinase 238 mutants that display compromised PP2A-B56 kinetochore localization. To test this, we 239 first arrested cells in prometaphase with nocodazole and induced mitotic exit by the 240 addition of the Mps1 inhibitor reversine. Control cells, and cells expressing BUBR1-WT 241 exited mitosis with similar kinetics. Strikingly, BUBR1-731X, -DKD and -SKD all caused a 242 delay in mitotic exit, indicating that the pseudokinase domain is required for efficient SAC 243 silencing (Fig 4A) . 244 Another important mitotic function of BUBR1-bound PP2A-B56 is to stabilize 245 kinetochore-fibers, and defects in this induce chromosome bi-orientation and end-on 246 conversion errors 23,24,28,60 . However, evidence regarding a role for the BUBR1 247 pseudokinase in chromosome alignment is inconsistent 42,49,52,54,61,62 , and we would argue 248 that this is likely due at least in part to the varying levels of mutant (in)stability. In an 249 attempt to address this, we measured alignment of kinetochores in MG132 arrested cells 250 after release from prometaphase arrest in our inducible cell lines and asked whether 251 pseudokinase mutants induce alignment errors when expressed at similar levels to 252 BUBR1-WT. We found that BUBR1 pseudokinase mutants, and BUBR1-731X exhibited 253 a consistent increase in the number of misaligned chromosomes (Fig 4B) . In agreement 254 with this, we found fewer stable K-fibers, a decrease in the number of kinetochores 255 attached to microtubules and shorter inter-kinetochore distances in BUBR1-731X, -SKD 256 and -DKD compared to BUBR1-WT (Suppl. Fig 4A-C) .
235

BUBR1 pseudokinase mutants undermine PP2A-B56 functions during mitosis
257
BUBR1-PP2A-B56 and Aurora B kinase activity inversely regulate outer-258 kinetochore phosphorylation to promote productive attachments 32, 35, 60 . Whereas Aurora 259 B inhibition causes misalignment as a result of too little kinase/too much phosphatase 260 activity in the presence of BUBR1-WT, the loss of PP2A-B56 activity in pseudokinase 261 mutants results in misalignment as a consequence of too much kinase/too little 262 phosphatase (Fig 4B and 23 ,24,28,60 ). We therefore reasoned that reducing Aurora B 263 activity in pseudokinase mutant expressing cells could restore the kinase-phosphatase 264 equilibrium and decrease the penetrance of chromosome misalignments (Fig 4C) . As 265 expected, Aurora B inhibition in metaphase increased the number of misaligned 266 chromosomes in BUBR1-WT expressing cells, but partially rescued the misalignment 267 observed in the pseudokinase mutants and BUBR1-731X (Fig 4D) . A similar conclusion 268 was reached when we measured kinetochore levels of Astrin, a marker of stable end-on 269 attachments 60,63 (Suppl. Fig 4D) . 270 The pseudokinase is required in cis for KARD phosphorylation 271 Our data so far suggests that optimal BUBR1 conformational stability imparted by 272 the pseudokinase domain is an important determinant of KARD phosphorylation. We 273 reasoned that substitution of the pseudokinase domain with the kinase domain of its 274 closest paralog hBUB1, to generate a MADBUB protein should have a stabilizing effect, 275 permitting KARD phosphorylation ( Fig. 5A) 38 . However, we find that while MADBUB was 276 13 expressed at equivalent levels to BUBR1-WT and able to localize to kinetochores, it was 277 unable to rescue KARD S676 phosphorylation ( Fig. 5B) . 278 To more rigorously test the requirement of the pseudokinase for KARD 279 phosphorylation, we asked whether its presence is required in cis or in trans, which we 280 tested using drug-induced heterodimerization 64,65 (Fig 5C) . When expressed in cells in 281 the absence of the small molecule heterodimerizer AP21967, the C-terminal fragment 282 encoding for the BUBR1 pseudokinase did not localize to kinetochores, consistent with 283 observations that kinetochore tethering of BUBR1 is mediated principally by its N-284 terminus 12,15,66-70 . Treatment with AP21967 resulted in kinetochore localization of the 285 pseudokinase and concomitant S676 phosphorylation ( Fig. 5D-F) . We interpret this to 286 mean that the KARD and pseudokinase domains need to be on the same polypeptide (or 287 at least in very close proximity) in order to achieve phosphorylation.
288
The requirement for the pseudokinase and KARD to be present in cis then led us 289 to hypothesize that a pseudokinase-specific interactor may be required for KARD 290 phosphorylation. The only known interacting partner of the BUBR1 kinase domain is the 291 kinesin motor Centromeric protein-E (CENP-E) 41,71,72 . If CENP-E is indeed required for 292 pseudokinase domain stability and KARD phosphorylation, then its depletion or 293 inactivation would be expected to attenuate SAC silencing and diminish B56 recruitment 294 to kinetochores. To test this, we either inhibited its motor activity using GSK923295 or 295 depleted it by siRNA, and observed mitotic exit after MPS1 inhibition by reversine in 296 nocodazole-treated cells as in Fig. 4A . Although we found a significant delay in SAC 297 silencing when B56 isoforms were depleted, neither CENP-E inhibition nor its depletion 298 had any influence on the kinetics of SAC exit, and these cells were indistinguishable from 299 14 controls (Fig 5G) . In full agreement with this, we find that CENP-E depletion did not impact 300 B56 kinetochore recruitment (Fig 5H, I) . 301 The finding that CENP-E played no discernable role in B56 recruitment and SAC 302 silencing was surprising, considering the effect of its inhibition on BUBR1 303 hyperphosphorylation documented by us and others [41] [42] [43] 73 . However, when we examined 304 KARD phosphorylation in CENP-E depleted cells further, we found that while S676 305 phosphorylation was reduced, as we have shown before, S670 phosphorylation was 306 increased ( 52 and Sup Fig 5A-B) . S670 phosphorylation has been shown to be the more 307 important of the two sites for B56 binding, which likely explains why we find no strong 308 requirement for CENP-E in B56 localization and SAC extinction 24, 27 . Moreover, the 309 interaction between BUBR1 and CENP-E was only appreciably disrupted in BUBR1-731X 310 but not in BUBR1-SKD and -DKD -expressing cells (Sup Fig 5C) . Therefore, we conclude 311 that pseudokinase-mediated coordination of KARD phosphorylation is not CENP-E 312 dependent.
313
BUB1
kinase-BUBR1 pseudokinase heterodimerization drives KARD 314 phosphorylation 315 Kinase-pseudokinase heterodimerization can exert allosteric regulation on their 316 respective activities 74-76 . We therefore reasoned that such cooperation may exist 317 between BUB1 and BUBR1. We first tested whether their interaction is required for KARD 318 phosphorylation independently of its function in BUBR1 kinetochore targeting by fusing 319 BUBR1 directly to MIS12, which is recruited constitutively to kinetochores. Indeed, 320 3xMYC-MIS12-BUBR1 was localized to kinetochores in both control and BUB1-depleted 321 cells, but we consistently observed a reduction in S676 phosphorylation in BUB1-depleted 322 15 cells compared to controls (Fig 6A; Suppl. Fig 6A) . Expression of truncated BUB1 323 lacking the C-terminal kinase domain (BUB1-KIN) also lead to reduced BUBR1 S676 324 phosphorylation levels (Fig 6B) . To confirm that the kinase domain of BUB1 regulates 325 KARD phosphorylation through the pseudokinase domain rather than another region of 326 BUBR1, we tested KARD phosphorylation in cells expressing BUBR1-731X, together with 327 BUB1-WT or BUB1-KIN. Because BUBR1-731X is hyperstable and can be expressed 328 at levels even higher than BUBR1-WT, low-level residual phosphorylation at S676 could 329 be detected when this protein was maximally expressed with doxycyline. Our results 330 demonstrate that S676 phosphorylation of BUBR1-731X remains unchanged between 331 cells expressing BUB1-WT or BUB1-KIN demonstrating that BUB1 regulation of KARD 332 phosphorylation requires the pseudokinase domain (Fig 6C) . Finally, given that BUB1 autophosphorylation of BUB1 at T589, in support of the notion that optimal BUB1 342 phosphorylation requires interaction with the BUBR1 pseudokinase domain (Fig 6D) . In 343 accordance with these results, we find that the BUBR1 KARD co-evolved with the BUB1 344 kinase domain, second only to the BUBR1 pseudokinase domain (Suppl. Fig. 6D ). Without structural information we can only speculate on the mechanism of how BUBR1 their optimal phosphorylation and activation. This type of mechanism has been previously 406 identified in other pseudokinases that function as activators of the partner kinase including 407 JAK2, STRADα and HER3 82-85 .
408
Finally, our work here may also shed light on the evolutionary history of BUBR1.
409
Previous phylogenomic studies indicated that MAD3/BUBR1 orthologs evolved through 410 numerous gene duplication and subfunctionalization events [38] [39] [40] . Our data support this Cytoskeleton) at 300 nM for 6 hours before starting imaging.
535
Immunofluorescence 536 Cells were seeded on cover slips and subsequently treated with the appropriate 537 dsiRNA after adhesion, followed by synchronization and drug treatment as indicated.
538
Cells were either simultaneously fixed and extracted by PTEMF (0.2% Triton X-100, 539 20mM PIPES pH 6.9, 1mM MgCl2, 10mM EGTA and 4% formaldehyde) or by pre-540 25 extraction (1% Triton X-100, 25mM PIPES pH 6.9, 2mM MgCl2, 10mM EGTA) followed 541 by fixation (25mM PIPES pH 6.9, 2mM MgCl2, 10mM EGTA and 4% formaldehyde), 542 depending on the antibody. After fixation, cells were blocked in 3% BSA in PBS and 543 incubated with antibodies for 1h at room temperature or 24h at 4°C, and then secondary 544 antibodies for 1-2h at room temperature. KARD Pseudokinase p = 3.4e-09 p = 3.1e-06 p = 1.6e-08 p = 0.015 p = 0.025 p = 3.4e-11 p = 0.741 p 
